Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Early Palliative Care on Overall Survival of Patients With Metastatic Upper Gastrointestinal Cancers, Treated With First-line Chemotherapy: a Randomized Phase III Trial

NCT02853474 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02853474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Early Palliative Care on Overall Survival of Patients With Metastatic Upper Gastrointestinal Cancers, Treated With First-line Chemotherapy: a Randomized Phase III Trial
Lead sponsor
Centre Oscar Lambret
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2022
Enrollment
480 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer, esophageal cancer, gastric cancer, gastroesophageal cancer, pancreas cancer